We looked for the effectiveness of low-dose long-term prescription of clarithromycin in
mustard-induced chronic pulmonary lesions, especially bronchiolitis obliterans
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Male.
Inclusion Criteria:
- His/her own will to participate
- Documented chemical exposure
- Clinical, spirometric and radiological findings were compatible with BO on High
Resolution Computed Tomography (HRCT)
Exclusion Criteria:
- any drug reactions during the trial
- history of sensitivity to macrolides
- diarrhea, gray stool, jaundice, eosinophilia, acute cholestatic hepatitis, pruritis,
dark urine, abdominal pain, osteomatosis, depression, taste change, behavioural
changes, early fatigue, odynophagia, glossitis , dizziness
- co-adminstration of: terfenadine, theophylline, carbamazepine, ergotamine,
dihydroergotamine, warfarin, cisapride, digoxin, triazolam, phenytoin, steroids, any
immunosuppressive, any systemic antibiotics
- using drugs that he/she cannot discontinue
- using drugs with potential interaction
- subject will to exit from the trial
- history of lobe resection of lung
- history of exacerbation in the last month prior to the beginning of trial
- continuous need to oxygen
- use of corticosteroids in last week prior to the trial beginning
- Radiographic evidence of pneumonia, active tuberculosis, lung carcinoma, or an
infection that necessitated the use of an antibiotic
- exacerbating of subjects
- creatinine srum level more than normal
- increasing ALT, AST levels
- total bilirubin more twice than normal
- subjects who did not use their drugs properly